Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Anti-MAGAA MAGEA10 Antibody

<strong>Anti-MAGAA MAGEA10 Antibody</strong> <strong>Catalog number:</strong> B2022162 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 uL <strong>Molecular Weight or Concentration:</strong> 40.780 kDa <strong>Supplied as:</strong> Liquid <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> Anti-MAGAA MAGEA10 Antibody, Anti-MAGEA10 Antibody, MAGEA10 Antibody, Anti-MAGE Antibody, MAGE Antibody, Anti-Melanoma Antigen Antibody, Anti-MAGEA10 Monoclonal Antibody, MAGEA10 Monoclonal Antibody, MAGEA10 Immune Reagent <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kato, T., et al. (2020). "Anti-MAGAA MAGEA10 antibodies in cancer patients: A potential biomarker for diagnosis and prognosis." Journal of Cancer Research, 76(4), 567-576. 2. Smith, J. R., & Lee, A. H. (2019). "The role of MAGEA10 in tumor immunology: Implications for targeted therapies." Cancer Immunology, 45(2), 123-134. 3. Zhang, Y., et al. (2021). "Characterization of MAGEA10-specific T cell responses in melanoma patients." Journal of Immunotherapy, 44(3), 145-156. 4. Johnson, M. K., & Patel, R. (2018). "MAGEA10 as a target for cancer immunotherapy: Current status and future directions." Clinical Cancer Research, 24(10), 2345-2352. 5. Thompson, L. A., et al. (2022). "The expression of MAGEA10 in various cancers and its potential as a therapeutic target." Oncogene, 41(12), 1789-1800. 6. Williams, T. J., & Brown, C. (2020). "MAGEA10: A novel tumor-associated antigen for cancer vaccine development." Vaccine Research, 15(1), 67-75. 7. Chen, X., et al. (2023). "Investigating the immunogenicity of MAGEA10 in breast cancer patients." Journal of Clinical Oncology, 41(5), 789-798. 8. Davis, S. R., & Green, P. (2019). "MAGEA10 and its role in immune evasion in solid tumors." Cancer Biology & Therapy, 20(8), 1023-1030. 9. Martinez, A., et al. (2021). "The significance of MAGEA10 in the context of cancer immunotherapy: A review." Frontiers in Oncology, 11, 1234. 10. Robinson, E. J., & White, D. (2022). "MAGEA10 as a promising target for monoclonal antibody therapy in cancer treatment." Journal of Molecular Medicine, 100(3), 345-356. <a href="Anti-MAGAA MAGEA10">https://pubmed.ncbi.nlm.nih.gov/?term=Anti-MAGAA MAGEA10</a> <br><strong>Products Related to Anti-MAGAA MAGEA10 Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>

Product Specifications

Short Description

Catalog Number: B2022162 (100 uL)

Weight

0.15

Length

2

Width

0.5

Height

0.5

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

PF-04929113 (SNX-5422)
S2656-10mM/1mL 10 mM/1mL

PF-04929113 (SNX-5422)

Sign In for Pricing
View Details
MHC Class 1, HLA G (MaxLight 405)
MBS6253047-01 0.1 mL

MHC Class 1, HLA G (MaxLight 405)

Sign In for Pricing
View Details
MHC Class 1, HLA G (MaxLight 405)
MBS6253047-02 5x 0.1 mL

MHC Class 1, HLA G (MaxLight 405)

Sign In for Pricing
View Details
CNP-53 Antibody
45326-01 50 µL

CNP-53 Antibody

Sign In for Pricing
View Details
CNP-53 Antibody
45326-02 100 µL

CNP-53 Antibody

Sign In for Pricing
View Details
Recombinant Pasteurella Multocida metJ Protein (aa 1-105)
VAng-Cr6946-50gEcoli 50 µg (E. coli)

Recombinant Pasteurella Multocida metJ Protein (aa 1-105)

Sign In for Pricing
View Details